These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1368493)

  • 1. Controversial comments.
    Jukes TH
    Biotechnology (N Y); 1992 Apr; 10(4):455; author reply 456. PubMed ID: 1368493
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversial comments.
    Miller HI
    Biotechnology (N Y); 1992 Apr; 10(4):454-5; author reply 456. PubMed ID: 1368492
    [No Abstract]   [Full Text] [Related]  

  • 3. Row over vaccine trial.
    Palca J
    Nature; 1988 Feb; 331(6156):470. PubMed ID: 3340199
    [No Abstract]   [Full Text] [Related]  

  • 4. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination as a triggering agent for the development of rheumatoid arthritis.
    Sharma A; Agarwal D; Kapoor S; Garg SR; Malaviya AN
    Int J Rheum Dis; 2011 Feb; 14(1):e8-9. PubMed ID: 21303474
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of rabies with a vaccine produced from recombinant DNA].
    Boll Chim Farm; 1991; 130(7):285-6. PubMed ID: 1756014
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs.
    Fekadu M; Nesby SL; Shaddock JH; Schumacher CL; Linhart SB; Sanderlin DW
    Vaccine; 1996 Apr; 14(6):465-8. PubMed ID: 8782341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal husbandry and biotechnology].
    Drost M
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):9-15. PubMed ID: 3469784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to purified chick embryo cell rabies vaccine.
    Dutta JK
    Vaccine; 1994 Nov; 12(15):1484. PubMed ID: 7887027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safety problems in biotechnology. Medical biotechnology and safety].
    Vorob'ev AA; Korovkin VI; Chugasova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):103-11. PubMed ID: 3324579
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.
    Charlton KM; Artois M; Prevec L; Campbell JB; Casey GA; Wandeler AI; Armstrong J
    Arch Virol; 1992; 123(1-2):169-79. PubMed ID: 1550495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warning: regulations can damage your health--the case of rabies.
    Pastoret PP; Boulanger D; Brochier B
    Curr Opin Biotechnol; 1994 Jun; 5(3):239-43. PubMed ID: 7765004
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies.
    Pastoret PP; Brochier B
    Dev Biol Stand; 1992; 79():105-11. PubMed ID: 1286744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.
    Brochier B; Thomas I; Bauduin B; Leveau T; Pastoret PP; Languet B; Chappuis G; Desmettre P; Blancou J; Artois M
    Vaccine; 1990 Apr; 8(2):101-4. PubMed ID: 2336870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species.
    Brochier B; Blancou J; Thomas I; Languet B; Artois M; Kieny MP; Lecocq JP; Costy F; Desmettre P; Chappuis G
    J Wildl Dis; 1989 Oct; 25(4):540-7. PubMed ID: 2681844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies and other lyssavirus diseases.
    Blanchard T
    Lancet; 2004 Jun; 363(9424):1906-7; author reply 1907. PubMed ID: 15183632
    [No Abstract]   [Full Text] [Related]  

  • 18. An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada.
    Sobey KG; Walpole AA; Rosatte R; Fehlner-Gardiner C; Donovan D; Bachmann P; Coulson S; Beresford A; Bruce L; Kyle CJ
    Vaccine; 2013 Apr; 31(17):2207-13. PubMed ID: 23499602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vaccine and initiative mean end of rabies in sight for Europe?
    Newmark P
    Nature; 1988 Dec; 336(6198):416. PubMed ID: 3194027
    [No Abstract]   [Full Text] [Related]  

  • 20. Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system.
    Fries LF; Tartaglia J; Taylor J; Kauffman EK; Meignier B; Paoletti E; Plotkin S
    Vaccine; 1996 Apr; 14(5):428-34. PubMed ID: 8735555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.